CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
To determine the relative risk of developing atopic dermatitis in infants fed a study formula based on whole goat milk compared to infants a study fo...
Valencia, Spain and 11 other locations
The main purpose of this study is to assess the long-term safety and efficacy of lebrikizumab in participants 6 Months to <18 years of age with moder...
Phase 3
Manises, València, Spain and 94 other locations
The main purpose of this study is to measure the effect, safety and how well the body absorbs lebrikizumab in pediatric participants 6 months to <18...
Phase 3
Manises, València, Spain and 96 other locations
This study is being conducted to establish the efficacy of ruxolitinib cream in participants with moderate AD who had an inadequate response to, or a...
Phase 3
Manises, Spain and 105 other locations
Global Assessment for Atopic Dermatitis (vIGA-AD).Evaluate the efficacy of rocatinlimab compared with placebo at Week 24, assessed using Eczema...
Phase 3
Valencia, Comunidad Valenciana, Spain and 196 other locations
, compared with placebo in combination with TCS/TCI at Week 24, assessed using Eczema Area and Severity Index (EASI)....
Phase 3
Valencia, Comunidad Valenciana, Spain and 234 other locations
This study is parallel group, placebo-controlled dose-ranging study to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of GSK10...
Phase 2
Valencia, Spain and 92 other locations
B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...
Phase 3
Valencia, Spain and 560 other locations
The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.
Phase 3
Valencia, Comunidad Valenciana, Spain and 407 other locations
The objective of this study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult participants with moderate...
Phase 3
Valencia, Spain and 195 other locations
Clinical trials
Research sites
Resources
Legal